Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biodel Inc (NASDAQ:BIOD)

0.72
Delayed Data
As of Sep 01
 +0.047 / +6.98%
Today’s Change
0.55
Today|||52-Week Range
2.05
-45.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$41.8M

Company Description

Biodel, Inc. is a specialty pharmaceutical company that develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT.

Contact Information

Biodel, Inc.
100 Saw Mill Road
Danbury Connecticut 06810
P:(203) 796-5000
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Errol B. De SouzaPresident, Chief Executive Officer & Director
Gary G. GemignaniChief Financial Officer
Alan Seth KrasnerChief Medical Officer
Paul S. BavierSecretary & Chief Administrative Officer